PortfoliosLab logoPortfoliosLab logo

ProShares UltraShort Nasdaq Biotechnology (BIS) belongs to the Leveraged Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with BIS. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to BIS

BIS charges 0.95% annually. There are 93 ETFs in the Leveraged Equities category with lower expense ratios, going as low as 0.35%.


Best Risk-Adjusted Alternatives to BIS

BIS has a PortfoliosLab risk / return rank of 1. There are 210 ETFs in the Leveraged Equities category with higher risk-adjusted ranks, going as high as 99.


Top Performing BIS Alternatives (YTD)

BIS is at -6.36% YTD. There are 198 ETFs in the Leveraged Equities category with higher YTD returns, going as high as 961.23%.


Lowest Volatility Alternatives to BIS

BIS has 39.68% 1-year volatility. There are 87 ETFs in the Leveraged Equities category with lower 1-year volatility, going as low as 4.70%.


Lowest Drawdown Alternatives to BIS

BIS has a 1-year max drawdown of -54.50%. There are 150 ETFs in the Leveraged Equities category with shallower 1-year drawdowns, going as shallow as -1.42%.


Other ETFs from ProShares

The 10 most viewed ProShares ETFs shown here include TQQQ, BITO, QLD and span 8 categories. AUM among these funds goes as high as $40B.


Often Compared With BIS

Investors most often compare BIS with BIB, RSPN, IBBQ. These 20 comparison targets span 10 categories, based on PortfoliosLab usage data.


SymbolNameCategoryRisk / Return RankYTD ReturnAUMInception
ProShares Ultra Nasdaq BiotechnologyLeveraged Equities
63
-0.51%
73.66MApr 2010BIS vs BIB
Invesco S&P 500® Equal Weight Industrials ETFIndustrials Equities, S&P 500
30
7.93%
1.01BJan 2006BIS vs RSPN
Invesco Nasdaq Biotechnology ETFHealth & Biotech Equities
67
1.91%
67.37MJun 2021BIS vs IBBQ
AdvisorShares Ranger Equity Bear ETFInverse Equities
8
5.43%
63.43MJan 2011BIS vs HDGE
Innovator IBD 50 ETFLarge Cap Growth Equities
30
20.11%
89.40MApr 2015BIS vs FFTY
State Street Health Care Select Sector SPDR ETFHealth & Biotech Equities
24
-4.29%
38.66BDec 1998BIS vs XLV
Nasdaq, Inc.
44
-10.34%
BIS vs NDAQ
Global X DAX Germany ETFEurope Equities
12
-0.66%
253.43MOct 2014BIS vs DAX
Invesco Dynamic Pharmaceuticals ETFHealth & Biotech Equities
64
2.90%
341.25MJun 2005BIS vs PJP
Vanguard Information Technology ETFTechnology Equities
76
31.64%
144.20BMar 2004BIS vs VGT
Leverage Shares 2X Long CMG Daily ETFLeveraged Equities
-45.23%
610.40KNov 2025BIS vs CMGG
GraniteShares 2x Long VRT Daily ETFLeveraged Equities
87
230.54%
76.71MMar 2025BIS vs VRTL
Leverage Shares 2X Long XYZ Daily ETFLeveraged Equities
9
-3.28%
3.61MApr 2025BIS vs XYZG
Leverage Shares 2X Long PYPL Daily ETFLeveraged Equities
1
-54.66%
21.07MApr 2025BIS vs PYPG
Direxion Daily GOOGL Bull 2X SharesLeveraged Equities
94
22.24%
1.35BSep 2022BIS vs GGLL
Leverage Shares 2X Long COST Daily ETFLeveraged Equities
17.32%
5.48MSep 2025BIS vs COTG
Direxion Daily Semiconductor Bull 3X ETFLeveraged Equities, Semiconductors
97
567.48%
22.99BMar 2010BIS vs SOXL
Leverage Shares 2X Long TSM Daily ETFLeveraged Equities
89
86.06%
23.74MJan 2025BIS vs TSMG
Roundhill BRKB WeeklyPay ETFDerivative Income, Leveraged Equities
-7.76%
15.27MJun 2025BIS vs BRKW
Leverage Shares 2X Long COIN Daily ETFLeveraged Equities
3
-61.85%
7.81MMar 2025BIS vs COIG

Compare BIS with Any Fund or Stock

Compare BIS with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


 

Diversifiers

Pair BIS with funds that move differently

ProShares UltraShort Nasdaq Biotechnology alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to BIS.

Explore BIS Diversifiers